Kim Jinho, O'Neill John D, Dorrello N Valerio, Bacchetta Matthew, Vunjak-Novakovic Gordana
Department of Biomedical Engineering, Columbia University, New York, NY 10027;
Department of Pediatrics, Columbia University, New York, NY 10029;
Proc Natl Acad Sci U S A. 2015 Sep 15;112(37):11530-5. doi: 10.1073/pnas.1512613112. Epub 2015 Aug 31.
The ability to deliver drugs to specific sites in the lung could radically improve therapeutic outcomes of a variety of lung diseases, including cystic fibrosis, severe bronchopneumonia, chronic obstructive pulmonary disease, and lung cancer. Using conventional methods for pulmonary drug administration, precise, localized delivery of exact doses of drugs to target regions remains challenging. Here we describe a more controlled delivery of soluble reagents (e.g., drugs, enzymes, and radionuclides) in microvolume liquid plugs to targeted branches of the pulmonary airway tree: upper airways, small airways (bronchioles), or the most distal alveoli. In this approach, a soluble liquid plug of very small volume (<1 mL) is instilled into the upper airways, and with programmed air ventilation of the lungs, the plug is pushed into a specific desired (more distal) airway to achieve deposition of liquid film onto the lung epithelium. The plug volume and ventilation conditions were determined by mathematical modeling of plug transport in a tubular geometry, and targeted liquid film deposition was demonstrated in rat lungs by three different in vivo imaging modalities. The experimental and modeling data suggest that instillation of microvolumes of liquid into a ventilated pulmonary airway could be an effective strategy to deliver exact doses of drugs to targeted pathologic regions of the lung, especially those inaccessible by bronchoscopy, to increase in situ efficacy of the drug and minimize systemic side effects.
将药物输送到肺部特定部位的能力可从根本上改善多种肺部疾病的治疗效果,这些疾病包括囊性纤维化、严重支气管肺炎、慢性阻塞性肺疾病和肺癌。使用传统的肺部给药方法,将精确剂量的药物精确、局部地输送到目标区域仍然具有挑战性。在此,我们描述了一种更可控的方法,即将微体积液体塞中的可溶性试剂(如药物、酶和放射性核素)输送到肺气道树的目标分支:上呼吸道、小气道(细支气管)或最远端的肺泡。在这种方法中,将非常小体积(<1 mL)的可溶性液体塞滴入上呼吸道,通过对肺部进行程序化通气,将液体塞推入特定的期望(更远端)气道,以实现液膜在肺上皮上的沉积。通过对管形结构中液体塞传输的数学建模确定了液体塞的体积和通气条件,并通过三种不同的体内成像方式在大鼠肺中证明了靶向液膜沉积。实验和建模数据表明,将微体积液体滴入通气的肺气道可能是一种有效的策略,可将精确剂量的药物输送到肺部的目标病理区域,尤其是那些支气管镜无法到达的区域,以提高药物的原位疗效并将全身副作用降至最低。